Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-05-064866
Filing Date
2005-03-30
Accepted
2005-03-30 14:38:13
Documents
5
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 930080
2 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex23.htm EX-23 2187
3 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER dex311.htm EX-31.1 6226
4 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER dex312.htm EX-31.2 6237
5 CERTIFICATION OF THE CHIEF FINANCIAL AND PRINCIPAL ACCOUNTING OFFICER dex32.htm EX-32 4822
  Complete submission text file 0001193125-05-064866.txt   951723
Mailing Address 1700 W. HORIZON RIDGE PARKWAY SUITE 100 HENDERSON NV 89012
Business Address 1700 W. HORIZON RIDGE PARKWAY SUITE 100 HENDERSON NV 89012 702-248-1174
CardioVascular BioTherapeutics, Inc. (Filer) CIK: 0001303497 (see all company filings)

EIN.: 330795984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-51172 | Film No.: 05713545
SIC: 2834 Pharmaceutical Preparations